Validation  ||| S:0 E:11 ||| NNP
and  ||| S:11 E:15 ||| CC
comparison  ||| S:15 E:26 ||| NN
of  ||| S:26 E:29 ||| IN
two  ||| S:29 E:33 ||| CD
methods  ||| S:33 E:41 ||| NNS
of  ||| S:41 E:44 ||| IN
measuring  ||| S:44 E:54 ||| VBG
lactate  ||| S:54 E:62 ||| NN
in  ||| S:62 E:65 ||| IN
equine  ||| S:65 E:72 ||| NNS
plasma  ||| S:72 E:79 ||| VBP
Some  ||| S:79 E:84 ||| DT
methods  ||| S:84 E:92 ||| NNS
of  ||| S:92 E:95 ||| IN
lactate  ||| S:95 E:103 ||| NNS
( ||| S:103 E:104 ||| -LRB-
LA ||| S:104 E:106 ||| NNP
)  ||| S:106 E:108 ||| -RRB-
measurement  ||| S:108 E:120 ||| NNS
have  ||| S:120 E:125 ||| VBP
not  ||| S:125 E:129 ||| RB
been  ||| S:129 E:134 ||| VBN
validated  ||| S:134 E:144 ||| JJ
appropriately  ||| S:144 E:158 ||| NN
for  ||| S:158 E:162 ||| IN
use  ||| S:162 E:166 ||| NN
in  ||| S:166 E:169 ||| IN
horses ||| S:169 E:175 ||| NNS
.  ||| S:175 E:177 ||| .
To  ||| S:177 E:180 ||| TO
validate  ||| S:180 E:189 ||| CD
2  ||| S:189 E:191 ||| CD
LA  ||| S:191 E:194 ||| NNP
analysers  ||| S:194 E:204 ||| NNS
( ||| S:204 E:205 ||| -LRB-
YSI  ||| S:205 E:209 ||| NNP
2300  ||| S:209 E:214 ||| CD
Stat  ||| S:214 E:219 ||| NNP
Plus  ||| S:219 E:224 ||| NNP
and  ||| S:224 E:228 ||| CC
TDx  ||| S:228 E:232 ||| NNP
Lactic  ||| S:232 E:239 ||| NNP
Acid  ||| S:239 E:244 ||| NNP
Assay ||| S:244 E:249 ||| NNP
)  ||| S:249 E:251 ||| -RRB-
for  ||| S:251 E:255 ||| IN
use  ||| S:255 E:259 ||| NN
with  ||| S:259 E:264 ||| IN
equine  ||| S:264 E:271 ||| JJ
plasma  ||| S:271 E:278 ||| NN
and  ||| S:278 E:282 ||| CC
to  ||| S:282 E:285 ||| TO
compare  ||| S:285 E:293 ||| VB
plasma  ||| S:293 E:300 ||| NNS
[ ||| S:300 E:301 ||| -LRB-
LA ||| S:301 E:303 ||| NNP
]  ||| S:303 E:305 ||| -RRB-
determined  ||| S:305 E:316 ||| VBN
by  ||| S:316 E:319 ||| IN
the  ||| S:319 E:323 ||| DT
2  ||| S:323 E:325 ||| CD
methods ||| S:325 E:332 ||| NNS
.  ||| S:332 E:334 ||| .
Both  ||| S:334 E:339 ||| DT
instruments  ||| S:339 E:351 ||| NNS
were  ||| S:351 E:356 ||| VBD
evaluated  ||| S:356 E:366 ||| VBN
for  ||| S:366 E:370 ||| IN
linearity ||| S:370 E:379 ||| NN
,  ||| S:379 E:381 ||| ,
parallelism ||| S:381 E:392 ||| NN
,  ||| S:392 E:394 ||| ,
recovery  ||| S:394 E:403 ||| NN
and  ||| S:403 E:407 ||| CC
precision  ||| S:407 E:417 ||| NN
using  ||| S:417 E:423 ||| VBG
serial  ||| S:423 E:430 ||| JJ
dilutions  ||| S:430 E:440 ||| NN
of  ||| S:440 E:443 ||| IN
standard  ||| S:443 E:452 ||| JJ
LA  ||| S:452 E:455 ||| NNP
solutions  ||| S:455 E:465 ||| NNS
and  ||| S:465 E:469 ||| CC
equine  ||| S:469 E:476 ||| JJ
plasma  ||| S:476 E:483 ||| NN
and  ||| S:483 E:487 ||| CC
then  ||| S:487 E:492 ||| RB
comparing  ||| S:492 E:502 ||| VBG
results  ||| S:502 E:510 ||| NNS
with  ||| S:510 E:515 ||| IN
linear  ||| S:515 E:522 ||| JJ
regression  ||| S:522 E:533 ||| NN
or  ||| S:533 E:536 ||| CC
paired  ||| S:536 E:543 ||| VBN
t  ||| S:543 E:545 ||| JJ
tests ||| S:545 E:550 ||| NNS
.  ||| S:550 E:552 ||| .
Plasma  ||| S:552 E:559 ||| NNP
[ ||| S:559 E:560 ||| -LRB-
LA ||| S:560 E:562 ||| NNP
]  ||| S:562 E:564 ||| -RRB-
results  ||| S:564 E:572 ||| NNS
were  ||| S:572 E:577 ||| VBD
compared  ||| S:577 E:586 ||| VBN
in  ||| S:586 E:589 ||| IN
275  ||| S:589 E:593 ||| CD
blood  ||| S:593 E:599 ||| NN
samples  ||| S:599 E:607 ||| NNS
collected  ||| S:607 E:617 ||| VBN
from  ||| S:617 E:622 ||| IN
horses  ||| S:622 E:629 ||| NNS
exercising  ||| S:629 E:640 ||| VBG
at  ||| S:640 E:643 ||| IN
various  ||| S:643 E:651 ||| JJ
intensities  ||| S:651 E:663 ||| NNS
using  ||| S:663 E:669 ||| VBG
Bland-Altman  ||| S:669 E:682 ||| JJ
analysis ||| S:682 E:690 ||| NN
.  ||| S:690 E:692 ||| .
Level  ||| S:692 E:698 ||| NN
of  ||| S:698 E:701 ||| IN
significance  ||| S:701 E:714 ||| NN
was  ||| S:714 E:718 ||| VBD
P  ||| S:718 E:720 ||| NN
< ||| S:720 E:722 ||| SYM
0.05 ||| S:722 E:726 ||| CD
.  ||| S:726 E:728 ||| .
YSI  ||| S:728 E:732 ||| NNP
exhibited  ||| S:732 E:742 ||| VBD
good  ||| S:742 E:747 ||| JJ
linearity  ||| S:747 E:757 ||| NN
for  ||| S:757 E:761 ||| IN
both  ||| S:761 E:766 ||| DT
LA  ||| S:766 E:769 ||| NNP
standards  ||| S:769 E:779 ||| NNS
and  ||| S:779 E:783 ||| CC
equine  ||| S:783 E:790 ||| JJ
plasma  ||| S:790 E:797 ||| NNS
( ||| S:797 E:798 ||| -LRB-
P  ||| S:798 E:800 ||| NNP
< ||| S:800 E:802 ||| SYM
0.05 ||| S:802 E:806 ||| CD
)  ||| S:806 E:808 ||| -RRB-
at  ||| S:808 E:811 ||| IN
0-30  ||| S:811 E:816 ||| CD
mmol ||| S:816 E:820 ||| CD
/ ||| S:820 E:821 ||| CD
l ||| S:821 E:822 ||| NN
.  ||| S:822 E:824 ||| .
TDx  ||| S:824 E:828 ||| NNP
had  ||| S:828 E:832 ||| VBD
good  ||| S:832 E:837 ||| JJ
linearity  ||| S:837 E:847 ||| NN
at  ||| S:847 E:850 ||| IN
0-12  ||| S:850 E:855 ||| FW
mmol ||| S:855 E:859 ||| FW
/ ||| S:859 E:860 ||| FW
l  ||| S:860 E:862 ||| FW
( ||| S:862 E:863 ||| -LRB-
P  ||| S:863 E:865 ||| NNP
< ||| S:865 E:867 ||| SYM
0.05 ||| S:867 E:871 ||| CD
) ||| S:871 E:872 ||| -RRB-
;  ||| S:872 E:874 ||| :
with  ||| S:874 E:879 ||| IN
LA  ||| S:879 E:882 ||| NNP
standard  ||| S:882 E:891 ||| JJ
solutions  ||| S:891 E:901 ||| NNS
> ||| S:901 E:902 ||| CD
12  ||| S:902 E:905 ||| CD
mmol ||| S:905 E:909 ||| CD
/ ||| S:909 E:910 ||| CD
l  ||| S:910 E:912 ||| NNS
and  ||| S:912 E:916 ||| CC
with  ||| S:916 E:921 ||| IN
equine  ||| S:921 E:928 ||| JJ
plasma ||| S:928 E:934 ||| NN
,  ||| S:934 E:936 ||| ,
linearity  ||| S:936 E:946 ||| NN
was  ||| S:946 E:950 ||| VBD
decreased ||| S:950 E:959 ||| VBN
.  ||| S:959 E:961 ||| .
YSI  ||| S:961 E:965 ||| NNP
exhibited  ||| S:965 E:975 ||| VBD
good  ||| S:975 E:980 ||| JJ
parallelism  ||| S:980 E:992 ||| NN
between  ||| S:992 E:1000 ||| IN
LA  ||| S:1000 E:1003 ||| NNP
standards  ||| S:1003 E:1013 ||| NNS
and  ||| S:1013 E:1017 ||| CC
equine  ||| S:1017 E:1024 ||| JJ
plasma  ||| S:1024 E:1031 ||| JJ
LA  ||| S:1031 E:1034 ||| NNP
measurements  ||| S:1034 E:1047 ||| NNS
throughout  ||| S:1047 E:1058 ||| IN
the  ||| S:1058 E:1062 ||| DT
0-30  ||| S:1062 E:1067 ||| FW
mmol ||| S:1067 E:1071 ||| FW
/ ||| S:1071 E:1072 ||| FW
l  ||| S:1072 E:1074 ||| FW
range  ||| S:1074 E:1080 ||| FW
( ||| S:1080 E:1081 ||| -LRB-
P  ||| S:1081 E:1083 ||| NNP
>  ||| S:1083 E:1085 ||| CD
0.05 ||| S:1085 E:1089 ||| CD
) ||| S:1089 E:1090 ||| -RRB-
.  ||| S:1090 E:1092 ||| .
Parallelism  ||| S:1092 E:1104 ||| NNP
was  ||| S:1104 E:1108 ||| VBD
poor  ||| S:1108 E:1113 ||| JJ
with  ||| S:1113 E:1118 ||| IN
TDx  ||| S:1118 E:1122 ||| NNP
( ||| S:1122 E:1123 ||| -LRB-
P  ||| S:1123 E:1125 ||| NNP
< ||| S:1125 E:1127 ||| SYM
0.05 ||| S:1127 E:1131 ||| CD
) ||| S:1131 E:1132 ||| -RRB-
.  ||| S:1132 E:1134 ||| .
Mean  ||| S:1134 E:1139 ||| VB
±  ||| S:1139 E:1141 ||| CD
s.d.  ||| S:1141 E:1146 ||| CD
%  ||| S:1146 E:1148 ||| NN
recovery  ||| S:1148 E:1157 ||| NN
was  ||| S:1157 E:1161 ||| VBD
101.7  ||| S:1161 E:1167 ||| CD
±  ||| S:1167 E:1169 ||| CD
3.4 ||| S:1169 E:1172 ||| CD
%  ||| S:1172 E:1174 ||| NN
for  ||| S:1174 E:1178 ||| IN
YSI  ||| S:1178 E:1182 ||| NNP
( ||| S:1182 E:1183 ||| -LRB-
acceptable ||| S:1183 E:1193 ||| JJ
)  ||| S:1193 E:1195 ||| -RRB-
and  ||| S:1195 E:1199 ||| CC
110.6  ||| S:1199 E:1205 ||| CD
±  ||| S:1205 E:1207 ||| CD
8.4 ||| S:1207 E:1210 ||| CD
%  ||| S:1210 E:1212 ||| NN
for  ||| S:1212 E:1216 ||| IN
TDx  ||| S:1216 E:1220 ||| NNP
( ||| S:1220 E:1221 ||| -LRB-
unacceptable ||| S:1221 E:1233 ||| LS
) ||| S:1233 E:1234 ||| -RRB-
.  ||| S:1234 E:1236 ||| .
Within-run  ||| S:1236 E:1247 ||| NNP
and  ||| S:1247 E:1251 ||| CC
mean  ||| S:1251 E:1256 ||| VB
between-run  ||| S:1256 E:1268 ||| JJ
coefficients  ||| S:1268 E:1281 ||| NN
of  ||| S:1281 E:1284 ||| IN
variation  ||| S:1284 E:1294 ||| NN
( ||| S:1294 E:1295 ||| -LRB-
CV ||| S:1295 E:1297 ||| NNP
)  ||| S:1297 E:1299 ||| -RRB-
for  ||| S:1299 E:1303 ||| IN
plasma  ||| S:1303 E:1310 ||| JJ
samples  ||| S:1310 E:1318 ||| NNS
tested  ||| S:1318 E:1325 ||| VBN
from  ||| S:1325 E:1330 ||| IN
3.3-29.5  ||| S:1330 E:1339 ||| CD
mmol ||| S:1339 E:1343 ||| CD
/ ||| S:1343 E:1344 ||| CD
l  ||| S:1344 E:1346 ||| NNS
were  ||| S:1346 E:1351 ||| VBD
0.4-3.0 ||| S:1351 E:1358 ||| CD
%  ||| S:1358 E:1360 ||| NN
for  ||| S:1360 E:1364 ||| IN
YSI ||| S:1364 E:1367 ||| NNP
.  ||| S:1367 E:1369 ||| .
CVs  ||| S:1369 E:1373 ||| JJ
for  ||| S:1373 E:1377 ||| IN
samples  ||| S:1377 E:1385 ||| NNS
tested  ||| S:1385 E:1392 ||| VBN
from  ||| S:1392 E:1397 ||| IN
2.8-8.0  ||| S:1397 E:1405 ||| CD
mmol ||| S:1405 E:1409 ||| CD
/ ||| S:1409 E:1410 ||| CD
l  ||| S:1410 E:1412 ||| NNS
were  ||| S:1412 E:1417 ||| VBD
17.4-24.1 ||| S:1417 E:1426 ||| CD
%  ||| S:1426 E:1428 ||| NN
for  ||| S:1428 E:1432 ||| IN
TDx ||| S:1432 E:1435 ||| JJ
.  ||| S:1435 E:1437 ||| .
In  ||| S:1437 E:1440 ||| IN
275  ||| S:1440 E:1444 ||| CD
plasma  ||| S:1444 E:1451 ||| CD
samples ||| S:1451 E:1458 ||| NNS
,  ||| S:1458 E:1460 ||| ,
[ ||| S:1460 E:1461 ||| -LRB-
LA ||| S:1461 E:1463 ||| NNP
]  ||| S:1463 E:1465 ||| -RRB-
ranged  ||| S:1465 E:1472 ||| VBD
from  ||| S:1472 E:1477 ||| IN
0.1-42.7  ||| S:1477 E:1486 ||| CD
mmol ||| S:1486 E:1490 ||| CD
/ ||| S:1490 E:1491 ||| CD
l  ||| S:1491 E:1493 ||| NNS
and  ||| S:1493 E:1497 ||| CC
0.3-50.6  ||| S:1497 E:1506 ||| CD
mmol ||| S:1506 E:1510 ||| CD
/ ||| S:1510 E:1511 ||| CD
l  ||| S:1511 E:1513 ||| NN
for  ||| S:1513 E:1517 ||| IN
the  ||| S:1517 E:1521 ||| DT
YSI  ||| S:1521 E:1525 ||| NNP
and  ||| S:1525 E:1529 ||| CC
TDx  ||| S:1529 E:1533 ||| JJ
methods ||| S:1533 E:1540 ||| NNS
,  ||| S:1540 E:1542 ||| ,
respectively ||| S:1542 E:1554 ||| RB
.  ||| S:1554 E:1556 ||| .
The  ||| S:1556 E:1560 ||| DT
difference  ||| S:1560 E:1571 ||| NN
in  ||| S:1571 E:1574 ||| IN
plasma  ||| S:1574 E:1581 ||| NNS
[ ||| S:1581 E:1582 ||| -LRB-
LA ||| S:1582 E:1584 ||| NNP
]  ||| S:1584 E:1586 ||| -RRB-
determined  ||| S:1586 E:1597 ||| VBN
by  ||| S:1597 E:1600 ||| IN
the  ||| S:1600 E:1604 ||| DT
2  ||| S:1604 E:1606 ||| CD
methods  ||| S:1606 E:1614 ||| NNS
was  ||| S:1614 E:1618 ||| VBD
-1.0  ||| S:1618 E:1623 ||| CD
±  ||| S:1623 E:1625 ||| CD
3.2  ||| S:1625 E:1629 ||| CD
mmol ||| S:1629 E:1633 ||| CD
/ ||| S:1633 E:1634 ||| CD
l ||| S:1634 E:1635 ||| NN
,  ||| S:1635 E:1637 ||| ,
documenting  ||| S:1637 E:1649 ||| VBG
that  ||| S:1649 E:1654 ||| IN
the  ||| S:1654 E:1658 ||| DT
TDx  ||| S:1658 E:1662 ||| JJ
overestimated  ||| S:1662 E:1676 ||| NNS
the  ||| S:1676 E:1680 ||| DT
YSI  ||| S:1680 E:1684 ||| NNP
results  ||| S:1684 E:1692 ||| NNS
by  ||| S:1692 E:1695 ||| IN
a  ||| S:1695 E:1697 ||| DT
mean  ||| S:1697 E:1702 ||| JJ
value  ||| S:1702 E:1708 ||| NN
of  ||| S:1708 E:1711 ||| IN
1  ||| S:1711 E:1713 ||| CD
mmol ||| S:1713 E:1717 ||| CD
/ ||| S:1717 E:1718 ||| CD
l ||| S:1718 E:1719 ||| NN
.  ||| S:1719 E:1721 ||| .
It  ||| S:1721 E:1724 ||| PRP
was  ||| S:1724 E:1728 ||| VBD
concluded  ||| S:1728 E:1738 ||| VBN
that  ||| S:1738 E:1743 ||| IN
the  ||| S:1743 E:1747 ||| DT
YSI  ||| S:1747 E:1751 ||| NNP
method  ||| S:1751 E:1758 ||| NN
was  ||| S:1758 E:1762 ||| VBD
a  ||| S:1762 E:1764 ||| DT
reliable  ||| S:1764 E:1773 ||| JJ
method  ||| S:1773 E:1780 ||| NN
for  ||| S:1780 E:1784 ||| IN
measuring  ||| S:1784 E:1794 ||| VBG
equine  ||| S:1794 E:1801 ||| JJ
plasma  ||| S:1801 E:1808 ||| NNS
[ ||| S:1808 E:1809 ||| -LRB-
LA ||| S:1809 E:1811 ||| NNP
]  ||| S:1811 E:1813 ||| -RRB-
from  ||| S:1813 E:1818 ||| IN
0-30  ||| S:1818 E:1823 ||| CD
mmol ||| S:1823 E:1827 ||| CD
/ ||| S:1827 E:1828 ||| CD
l ||| S:1828 E:1829 ||| NN
.  ||| S:1829 E:1831 ||| .
The  ||| S:1831 E:1835 ||| DT
TDx  ||| S:1835 E:1839 ||| JJ
method  ||| S:1839 E:1846 ||| NN
was  ||| S:1846 E:1850 ||| VBD
found  ||| S:1850 E:1856 ||| VBN
not  ||| S:1856 E:1860 ||| RB
to  ||| S:1860 E:1863 ||| TO
be  ||| S:1863 E:1866 ||| VB
suitable  ||| S:1866 E:1875 ||| JJ
for  ||| S:1875 E:1879 ||| IN
use  ||| S:1879 E:1883 ||| NN
with  ||| S:1883 E:1888 ||| IN
equine  ||| S:1888 E:1895 ||| JJ
plasma  ||| S:1895 E:1902 ||| JJ
due  ||| S:1902 E:1906 ||| JJ
to  ||| S:1906 E:1909 ||| TO
greater  ||| S:1909 E:1917 ||| JJR
variability  ||| S:1917 E:1929 ||| NN
in  ||| S:1929 E:1932 ||| IN
measurements  ||| S:1932 E:1945 ||| NNS
( ||| S:1945 E:1946 ||| -LRB-
high  ||| S:1946 E:1951 ||| JJ
CV ||| S:1951 E:1953 ||| NNP
) ||| S:1953 E:1954 ||| -RRB-
.  ||| S:1954 E:1956 ||| .
